Top

Published in:

01-01-2022 | Autoimmune Pancreatitis | UNM CLINICAL CASE CONFERENCES

A Transient Treatable Tumor of the Pancreas

Authors: Vaishnavi Boppana, Swathi Paleti, Christina Ling, Nicholas Volpicelli, Denis McCarthy

Published in: Digestive Diseases and Sciences | Issue 1/2022

Excerpt

A 64-year-old male was evaluated in the emergency department with a 2-week history of jaundice, dark urine, and pale stools. He also reported a 25 lb. unintentional weight loss over the previous 3 months but had no other symptoms. His medical history included hyperlipidemia, obstructive sleep apnea, and allergic rhinitis; his surgical history and family history were negative. His social history included smoking cigarettes, 1 pack per day for 11 years, but he denied any use of alcohol or illicit drugs. His physical examination was unremarkable apart from scleral icterus and jaundice. At no point had salivary glands been enlarged. …

Meng Q, Xin L, Liu W, Lin H et al. Diagnosis and treatment of autoimmune pancreatitis in china: a systematic review. PLoS One. 2015;10:e0130466. https://doi.org/10.1371/journal.pone.0130466.CrossRefPubMedPubMedCentral

Sarles H, Sarles JC, Camatte R, Muratore R et al. Observations on 205 confirmed cases of acute pancreatitis, recurring pancreatitis, and chronic pancreatitis. Gut. 1965;6:545–559.CrossRef

Yoshida K, Toki F, Takeuchi T, Watanabe S et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995;40:1561–1568. https://doi.org/10.1007/BF02285209.CrossRefPubMed

Schneider A, Michaely H, Weiss C, Hirth M et al. Prevalence and incidence of autoimmune pancreatitis in the population living in the Southwest of Germany. Digestion. 2017;96:187–198.CrossRef

Sah RP, Pannala R, Chari ST, Sugumar A et al. Prevalence, diagnosis, and profile of autoimmune pancreatitis presenting with features of acute or chronic pancreatitis. Clin Gastroenterol Hepatol 2010;8:91–96.CrossRef

Chari ST, Kloeppel G, Zhang L, Notohara K et al. Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document. Pancreas. 2010;3:549–554.CrossRef

Klöppel G, Detlefsen S, Chari ST, Longnecker DS, Zamboni G. Autoimmune pancreatitis: the clinicopathological characteristics of the subtype with granulocytic epithelial lesions. J Gastroenterol 2010;45:787–793.CrossRef

Notohara K, Burgart LJ, Yadav D, Chari S, Smyrk TC. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol. 2003;27:1119–1127.CrossRef

Deshpande V, Chicano S, Finkelberg D, Selig M et al. Autoimmune pancreatitis: a systemic immune complex mediated disease. Am J Surg Pathol. 2006;30:1537–1545.CrossRef

10.

Okamoto A, Watanabe T, Kamata K, Minaga K, Kudo M. Recent updates on the relationship between cancer and autoimmune pancreatitis. Intern Med. 2019;58:1533–1539.CrossRef

11.

Masamune A, Kikuta K, Hamada S, Tsuji I et al. Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016. J Gastroenterol. 2020;55:462–470.CrossRef

12.

Drake M, Dodwad SJ, Davis J, Kao LS et al. Sex-related differences of acute and chronic pancreatitis in adults. J Clin Med. 2021. https://doi.org/10.3390/jcm10020300.CrossRefPubMedPubMedCentral

13.

Zhang L, Smyrk TC. Autoimmune pancreatitis and IgG4-related systemic diseases. Int J Clin Exp Pathol. 2010;3:491–504.PubMedPubMedCentral

14.

Kamisawa T, Chari ST, Giday SA, Kim M-H et al. Clinical profile of autoimmune pancreatitis and its histological subtypes: an international multicenter survey. Pancreas. 2011;40:809–814.CrossRef

15.

Yoon SB, Moon S-H, Kim JH, Song TJ, Kim M-H. The use of immunohistochemistry for IgG4 in the diagnosis of autoimmune pancreatitis: a systematic review and meta-analysis. Pancreatology. 2020;20:1611–1619.CrossRef

16.

Chang MC, Liang PC, Jan S, Yang CY et al. Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels. Pancreatology. 2014;14:366–372.CrossRef

17.

Takahashi M, Fujinaga Y, Notohara K, Koyama T et al. Diagnostic imaging guide for autoimmune pancreatitis. Jpn J Radiol 2020;38:591–612.CrossRef

18.

Conti CB, Cereatti F, Drago A, Grassia R. Focal autoimmune pancreatitis: a simple flow chart for a challenging diagnosis. Ultrasound Int Open. 2020;6:E67–E75. https://doi.org/10.1055/a-1323-4906.CrossRefPubMed

19.

Buscarini E, De Lisi S, Arcidiacono PG, Petrone MC et al. Endoscopic ultrasonography findings in autoimmune pancreatitis. World J Gastroenterol. 2011;17:2080–2085.CrossRef

20.

Noguchi K, Nakai Y, Mizuno S, Hirano K et al. Role of endoscopic ultrasonography-guided fine needle aspiration/biopsy in the diagnosis of autoimmune pancreatitis. Diagnostics (Basel). 2020;10:954.CrossRef

21.

Okazaki K, Chari ST, Frulloni L, Lerch MM et al. International consensus for the treatment of autoimmune pancreatitis. Pancreatology. 2017;17:1–6.CrossRef

22.

Masamune A, Nishimori I, Kikuta K, Tsuji I et al. Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis. Gut. 2017;66:487–494.CrossRef

23.

Soliman H, Vullierme M-P, Maire F, Hentic O et al. Risk factors and treatment of relapses in autoimmune pancreatitis: Rituximab is safe and effective. United Eur Gastroenterol J. 2019;7:1073–1083.CrossRef

Title: A Transient Treatable Tumor of the Pancreas
Authors: Vaishnavi Boppana
Swathi Paleti
Christina Ling
Nicholas Volpicelli
Denis McCarthy
Publication date: 01-01-2022
Publisher: Springer US
Keywords: Autoimmune Pancreatitis
Pancreatitis
Pancreatic Cancer
Pancreatic Cancer
Published in: Digestive Diseases and Sciences / Issue 1/2022
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI: https://doi.org/10.1007/s10620-021-07261-2

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

A Transient Treatable Tumor of the Pancreas

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

Impact of Fellow Participation During Colonoscopy on Adenoma Detection Rates

No Evidence Indicates Famotidine Reduces the Risk of Serious Disease in COVID-19 Patients After Propensity Score Matching: Meta-Analysis and Systematic Reviews

Retraction Note to: Akt2-Dependent Phosphorylation of Radixin in Regulation of Mrp-2 Trafficking in WIF-B Cells

Disparities in Telehealth for Liver Disease: Revealing What Was Hidden in Plain Sight

Update: Innate Lymphoid Cells in Inflammatory Bowel Disease

Efficacy and Safety of Antofloxacin-Based Triple Therapy for Helicobacter pylori Eradication Failure in China

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page